Search research articles
Contact Us
Filters
Showing results (561-570 of 575) with videos related to
Page
of 58
Sort By:
Nature Communications
|
August 6, 2025
Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression
Leo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Nature Communications
|
February 2, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Marcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
Clinical Lung Cancer
|
May 19, 2018
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies
Fred R Hirsch, Keith M Kerr, Paul A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2026
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005
Kristin A Higgins, Chen Hu, Helen J Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2023
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, et al.
The Lancet. Oncology
|
February 24, 2015
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A Rizvi, Julien Mazières, David Planchard, et al.
JAMA
|
June 1, 2026
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial
Jamie E Chaft, Zhuoxin Sun, Charles M Rudin, et al.
Nature Medicine
|
January 17, 2025
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial
Alicia F C Okines, Giuseppe Curigliano, Nobumasa Mizuno, et al.
Nature Genetics
|
July 3, 2013
An atlas of over 90,000 conserved noncoding sequences provides insight into crucifer regulatory regions
Annabelle Haudry, Adrian E Platts, Emilio Vello, et al.
Scientific Data
|
December 18, 2024
Active and passive organic carbon fluxes during a bloom in the Southern Ocean (South Georgia)
William Major, Sarah L C Giering, Joanna Ainsworth, et al.
Page
of 58
Search research articles
Search
Showing results (561-570 of 575) with videos related to
Sort By:
Page
of 58
Nature Communications
|
August 6, 2025
Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression
Leo Carl Foerster, Oguzhan Kaya, Valentin Wüst, et al.
Nature Communications
|
February 2, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Marcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
Clinical Lung Cancer
|
May 19, 2018
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies
Fred R Hirsch, Keith M Kerr, Paul A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2026
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005
Kristin A Higgins, Chen Hu, Helen J Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2023
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, et al.
The Lancet. Oncology
|
February 24, 2015
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A Rizvi, Julien Mazières, David Planchard, et al.
JAMA
|
June 1, 2026
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial
Jamie E Chaft, Zhuoxin Sun, Charles M Rudin, et al.
Nature Medicine
|
January 17, 2025
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial
Alicia F C Okines, Giuseppe Curigliano, Nobumasa Mizuno, et al.
Nature Genetics
|
July 3, 2013
An atlas of over 90,000 conserved noncoding sequences provides insight into crucifer regulatory regions
Annabelle Haudry, Adrian E Platts, Emilio Vello, et al.
Scientific Data
|
December 18, 2024
Active and passive organic carbon fluxes during a bloom in the Southern Ocean (South Georgia)
William Major, Sarah L C Giering, Joanna Ainsworth, et al.
Page
of 58